cvrx.com (CVRX) Company Sales Volume

Corporate emblem and logo of CVRx Inc. (CVRX)

Slow insurance reimbursement rates and personnel costs are hindering CVRx, Inc. (CVRX) on its path to profitability. The company's goods sold reflect current revenue dynamics, where 0.06 represents the latest metric reading. Growth is driven by the implementation of the Barostim system and direct sales. Risks are being mitigated through the development of neurostimulators for patients with severe heart failure that is unresponsive to standard treatment.

Company Sales: CVRx, Inc. (CVRX) for 07/04/2022 - 11/13/2026

Analytical breakdowns for CVRx (CVRX)

- market value and analyst target forecast:
Market Chart CVRx Inc|CVRX - Price Target Chart
- market capitalization details:
Market Capitalization CVRx|CVRX - Enterprise Value
- issuer book value statistics:
Accounting Value per Share CVRx, Inc.|CVRX - Company Net Assets|Market Capitalization to Book Value cvrx.com|CVRX - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio CVRx, Inc.|CVRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity CVRx Inc.|CVRX - Company Debts|Debt to Net Assets Ratio CVRx|CVRX - Company Long-Term Liabilities|Company Short-Term Indebtedness CVRx, Inc.|Intermediate Coverage Ratio cvrx.com
- company profitability and valuation multiples indicators:
CVRX - Net Profit|Expected Net Profit CVRx, Inc.|CVRX - P/E Multiple|Forward P/E Multiple cvrx.com|CVRX - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation CVRx|CVRX - Operating profit before deduction of amortization|Earnings per share for the last four quarters CVRx, Inc.|CVRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months cvrx.com|CVRX - Net earnings per share growth this year|Net earnings per share growth forecast for next year CVRx, Inc.
- issuer revenue and sales details:
CVRX - Company Revenue|Company Future Revenue CVRx Inc|CVRX - Market Cap to Revenue|Market Cap to Projected Revenue CVRx
Comprehensive company analysis:CVRx Inc - CVRX
Signature product of CVRx Inc.

This metric reflects operational efficiency by monitoring actual revenue inflow. The indicator captures daily sales volume, allowing the market to filter out noise and identify a sustainable trend. For CVRx, Inc. (CVRX), growth in this metric confirms the success of expanding the sales representative workforce for stimulation systems. It is critical for investors to benchmark current values against historical markers. By analyzing the company's aggregated sales, one can promptly detect deviations from planned growth rates.

Competing companies

Regeneron Corp (REGN) - Company Gross Revenue|Company Revenue iRhythm Technologies (IRTC)|lantheus.com - Company Sales Volume|Revenue and Sales Volume MLYS (Mineralys Therapeutics, Inc.)|HTFL - Company Sales|KMTS: Company Sales|Company Gross Revenue Esperion Corp ESPR|AMRN: Revenue and Sales Volume|Company Sales Anteris Technologies|Company Sales TNYA|Company Revenue MIST|Company Revenue Cardiol Therapeutics (CRDL)|BEAT (HeartBeam Corporation) - Company Sales Revenue|Tenax Therapeutics - Company Sales|ADGM: Company Sales Volume|BioCardia - Revenue and Sales Volume|Company Sales Revenue VTAK (Catheter Precision Inc)|ABIO: Revenue and Sales Volume|Company Total Revenue Acasti Pharma Inc. (ACST)|AVTE (Aerovate Therapeutics) - Revenue and Sales Volume|Revenue and Sales Volume Verve|Company Revenue Windtree Therapeutics (WINT)